Douglas Janzen

Douglas Janzen

Chief Executive Officer at AEQUUS PHARMACEUTICALS INC.

Net worth: 138 092 $ as of 2024-03-30

56 year
Health Technology
Commercial Services
Finance

Profile

Douglas Glen Janzen is the founder and currently holds the position of Chairman, President & Chief Executive Officer at Aequus Pharmaceuticals, Inc., which was founded in 2013.
He is also the founder and currently serves as President, Chief Executive Officer & MD at Northview Ventures, Inc., founded in 2012.
Additionally, he is the founder and currently holds the position of Managing Director at Northview Ventures & Associates General Partnership, founded in 2014.
Mr. Janzen's current job(s) include being the Chairman at Lexington Biosciences Holdings Corp., starting in 2017.
He is also the Director & Managing Director at LifeSciences British Columbia since 2010, an Independent Director at Neovasc, Inc. since 2005, and a Director at Perimeter Medical Imaging, Inc., Synaptive Technologies Ltd., Transdermal Research Pharm Laboratories LLC, and Alabaster Technologies, Inc. In his former positions, Mr. Janzen served as the President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2003 to 2012.
He was also the Chairman at AbCellera Biologics, Inc. and Lexington Biosciences, Inc. from 2016 to 2021.
Furthermore, he held various director positions at Medical Ventures Corp., Teal Valley Health, Inc., Aptamera, Inc., Synaptive Medical, Inc., BIOTECanada, iCo Therapeutics, Inc., Sentinelle Medical ULC, BioHEP Technologies Ltd., Renaissance BioScience Corp., AmpHP, Inc., and Perimeter Medical Imaging AI, Inc. He also worked as an Analyst at Cormark Securities, Inc. in 2002 and served as the President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007.
Prior to that, he was the Head of Research at Loewen, Ondaatje, McCutcheon Ltd.
from 1998 to 2001.
Mr. Janzen's education includes a graduate degree from the University of British Columbia and an undergraduate degree from the University of Saskatchewan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-19 12,553,800 ( 9.46% ) 138 092 $ 2024-03-30

Douglas Janzen active positions

CompaniesPositionStart
NEOVASC INC. Director/Board Member 2005-06-01
AEQUUS PHARMACEUTICALS INC. Chief Executive Officer 2013-01-02
Alabaster Technologies, Inc. Director/Board Member -
Chairman 2017-05-22
Chief Executive Officer 2014-03-31
Transdermal Research Pharm Laboratories LLC Director/Board Member 2013-03-02
Synaptive Technologies Ltd. Director/Board Member -
Northview Ventures, Inc. Chief Executive Officer 2012-10-31
Director/Board Member -
All active positions of Douglas Janzen

Former positions of Douglas Janzen

CompaniesPositionEnd
░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Douglas Janzen's experience

Training of Douglas Janzen

University of British Columbia Graduate Degree
University of Saskatchewan Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Janzen's experience

Connections

100 +

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
AEQUUS PHARMACEUTICALS INC.

Health Technology

ABCELLERA BIOLOGICS INC.

Health Technology

REGISTERED PLAN PRIVATE INVESTMENTS INC.

Health Technology

PERIMETER MEDICAL IMAGING AI, INC.

Health Technology

Private companies23

Finance

Health Technology

Electronic Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Northview Ventures, Inc.

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Health Technology

Alabaster Technologies, Inc.

Health Technology

Transdermal Research Pharm Laboratories LLC

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Douglas Janzen